Heart Test Laboratories has a Cash Ratio of 4.15. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.
The historical rank and industry rank for Heart Test Laboratories's Cash Ratio or its related term are showing as below:
HSCS'
s Cash Ratio Range Over the Past 10 Years
Min: 0.03 Med: 0.65 Max: 4.15
Current: 4.15
During the past 4 years, Heart Test Laboratories's highest Cash Ratio was 4.15. The lowest was 0.03. And the median was 0.65.
HSCS's Cash Ratio is ranked better than 80.68% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.2
vs HSCS: 4.15
Heart Test Laboratories Cash Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Heart Test Laboratories's Cash Ratio
For the Medical Devices subindustry, Heart Test Laboratories's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Heart Test Laboratories's Cash Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Heart Test Laboratories's Cash Ratio distribution charts can be found below:
* The bar in red indicates where Heart Test Laboratories's Cash Ratio falls into.
Heart Test Laboratories Cash Ratio Calculation
The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.
Heart Test Laboratories's Cash Ratio for the fiscal year that ended in Apr. 2023 is calculated as:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Heart Test Laboratories (NAS:HSCS) Cash Ratio Explanation
The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.
The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.
In general, the higher the cash ratio, the better the company's liquidity position.
Heart Test Laboratories Cash Ratio Related Terms
Thank you for viewing the detailed overview of Heart Test Laboratories's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Heart Test Laboratories (Heart Test Laboratories) Business Description
Heart Test Laboratories Inc is a medical technology company focused on applying innovative AI-based technology to an ECG to expand and improve an ECG's clinical usefulness. The objective of the company is to make an ECG a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HSCS has been successfully added to your 